Notification letter and request form for non-registered shareholders
Filed with HKEX · Stock code 1177 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communication are now available on the Company’s website at www.sbpgroup.com and the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version of the Current Corporate Communication and all fut
Sino Biopharmaceutical Limited on 6ix
Earlier from Sino Biopharmaceutical
- Notification letter and reply form for registered shareholders
- 2026 Interim report
- Voluntary announcement - acceptance of new drug application for TQH2722 injection
- Voluntary announcement - acceptance of new drug application for TQB2102 injection "HER2 bispecific adc"
- Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
Later from Sino Biopharmaceutical
- Voluntary announcement - enter into strategic biosimilars partnership with STADA
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Voluntary announcement - completion of all subjects enrollment in the phase iii registrational clinical trial of TQC3721 inhalation suspension "PDE3/4 inhibitor"
- Next day disclosure return
- Voluntary announcement - latest research results on tq-A3334 "TLR7 agonist" and bepirovirsen "aso" to be presented at 2026 aasld
Follow Sino Biopharmaceutical into a list and get an email when it puts out news.
Follow Sino Biopharmaceutical